Completed PHASE4 INTERVENTIONAL 4-arm NCT03075657

Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia

Sponsor: All India Institute of Medical Sciences, Bhubaneswar

Interventions Haloperidol Haloperidol and Ramelteon Risperidone Risperidone and Ramelteon

Updated 9 times since 2017 Last updated: May 2, 2019 Started: May 1, 2017 Primary completion: Jun 15, 2018 Completion: Aug 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Schizophrenia and is currently completed. All India Institute of Medical Sciences, Bhubaneswar leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2019 — Jan 2021 [monthly]

Completed PHASE4
Dec 2018 — Jun 2019 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed

▶ Show 4 earlier versions

Jul 2018 — Dec 2018 [monthly]

Active Not Recruiting PHASE4

Status: Recruiting → Active Not Recruiting
Jun 2018 — Jul 2018 [monthly]

Recruiting PHASE4
Jun 2017 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Apr 2017 — Jun 2017 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

All India Institute of Medical Sciences, Bhubaneswar

Data source: All India Institute of Medical Sciences, Bhubaneswar

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bhubaneswar, India